✦ LIBER ✦

Immunostimulation in Crohn's disease: Results of a pilot study of G-CSF (r-metHuG-CSF) in mucosal and fistulizing Crohn's disease

✍ Scribed by Korzenik, Joshua Raphael; Dieckgraefe, Brian Keith

Book ID: 122021142
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 320 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)85638-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune stimulation in Crohn's disease: S

Immune stimulation in Crohn's disease: Safety and efficacy of rhuGM-CSF for the treatment of active Crohn's disease

✍ Korzenik, Joshua R.; Dieckgraete, Brian K. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 372 KB

S1129 Determinants of Hyperoxaluria and

S1129 Determinants of Hyperoxaluria and Urolithiasis in Crohn's Disease: Results of a Pilot Study

✍ Tessa Romkens; Fokko Nagengast; Dirk J. De Jong 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The use of G-CSF for 6-mercaptopurine in

The use of G-CSF for 6-mercaptopurine induced leukopenia in a patient with Crohn’s disease

✍ Christopher S Huang; Stephen Sentovich; Francis A Farraye 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 35 KB

Intestinal lavage in the treatment of cr

Intestinal lavage in the treatment of crohn's disease: A pilot study

✍ Wellmann, W. ;Schmidt, F. W. 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

Sa1992 Mucosal Healing With the Specific

Sa1992 Mucosal Healing With the Specific Carbohydrate Diet in Pediatric Crohn's Disease: Preliminary Results of a Prospective Pilot Study

✍ Cohen, Stanley A.; Stallworth, Angela N.; Koch, Bailey M.; Mason, David H.; Blum 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Combined approach with infliximab, surge

Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study

✍ Pauline Roumeguère; Dominique Bouchard; François Pigot; Alain Castinel; Frederic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Background: Infliximab is the only medical therapy that has been proven to be effective in fistulizing Crohn's disease (CD), but the recurrence rate of fistulas is high despite maintenance therapy. The aim of this prospective study was to evaluate the short-and long-term efficacy of a combined sched